Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
8.93
+0.05 (0.56%)
Dec 3, 2025, 4:00 PM EST - Market closed
Ardent Health Revenue
Ardent Health had revenue of $1.58B in the quarter ending September 30, 2025, with 8.75% growth. This brings the company's revenue in the last twelve months to $6.33B, up 10.86% year-over-year. In the year 2024, Ardent Health had annual revenue of $5.97B with 10.29% growth.
Revenue (ttm)
$6.33B
Revenue Growth
+10.86%
P/S Ratio
0.20
Revenue / Employee
$254,038
Employees
24,900
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.97B | 556.59M | 10.29% |
| Dec 31, 2023 | 5.41B | 279.80M | 5.45% |
| Dec 31, 2022 | 5.13B | 259.29M | 5.32% |
| Dec 31, 2021 | 4.87B | 708.52M | 17.02% |
| Dec 31, 2018 | 4.16B | 1.16B | 38.79% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ARDT News
- 19 hours ago - ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 22 hours ago - ARDT NEWS: Ardent Health, Inc. Investigated for Securities Violations after Stock Plummets 33% -- Investors Notified to Contact BFA Law - GlobeNewsWire
- 7 days ago - Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman - PRNewsWire
- 8 days ago - Ardent Health, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 9 days ago - ARDENT NOTICE: Ardent Health, Inc. (ARDT) Faces Securities Investigation after Stock Drops 33%, Investors Urged to Contact BFA Law - Newsfile Corp
- 12 days ago - ARDT SHAREHOLDERS: A Securities Investigation into Ardent Health, Inc. has been Initiated on behalf of Investors -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 14 days ago - ARDT INVESTIGATION: Ardent Health, Inc. Investors that Suffered Losses are Notified to Contact BFA Law about the Ongoing Securities Investigation - Newsfile Corp
- 14 days ago - ARDT STOCK: Ardent Health, Inc. Investigated for Securities Violations after Revenue Drop Causes 33% Stock Drop -- Investors Notified to Contact BFA Law - GlobeNewsWire